Feng Xue

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Second Hospital of Shandong University, Institute of Hematology & Blood Diseases Hospital, Qilu Hospital of Shandong University, Sichuan Normal University · ORCID：0000-0002-5947-3924

发表论文 201 篇 · 总被引 1996 次 · h-index 25

代表论文

• Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials (2025 · Nature Medicine · 被引 9)
• Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial (2025 · BMJ · 被引 6)
• Argonaute combined with isothermal amplification for simultaneous detection of Vibrio parahaemolyticus and the tetracycline resistance gene tetA in water and food samples (2025 · Current Research in Food Science · 被引 6)
• Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025) (2025 · Blood Science · 被引 3)
• Defect-rich intermetallic Pt3Sn nanocrystals as colorimetric signal amplifiers for sensitive immunochromatographic detection of early-stage bacterial contamination (2025 · Journal of Hazardous Materials · 被引 2)
• The effectiveness and safety of various treatments for hemophilia in China: a literature review and evidence mapping (2025 · Hematology · 被引 2)